Last reviewed · How we verify

NCT03244293: BIS6

Bispectral Index (BIS) for Classification of Procalcitonin (PCT) Sepsis Grades in Critically Ill Patients With Sepsis

Status unknown Last updated 22 November 2023
What this trial tests

trial testing no intervention in Sepsis, Severe in 20 participants. Status unknown.

Timeline
1 January 2014
Primary endpoint
1 December 2025
1 December 2025

Quick facts

Lead sponsorSuez Canal University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment20
Start date1 January 2014
Primary completion1 December 2025
Estimated completion1 December 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Suez Canal University

Who can join

Eligibility, any sex, with Sepsis, Severe. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the discriminative power of BIS monitoring to classify the degree of mental state associated with the PCT graded sepsis cascade, and to assess its utility for monitoring the improvement or deterioration of sepsis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

Other recruiting trials for Sepsis, Severe

Currently open trials in the same condition.

Other Suez Canal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03244293.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing